Log in to search using one of your social media accounts:

 

GlaxoSmithKline adult shingles vaccine wins U.S. approval
(Reuters) - The U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected after an advisory panel to the agency last month voted unanimously to recommend its approval, the company announced on Friday. (Source: Reuters: Health)
Source: Reuters: Health - October 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

GSK ’s Shingrix receives approval in Canada to prevent shingles
GlaxoSmithKline ’s (GSK) non-live, recombinant sub-unit, adjuvanted vaccine Shingrix has received approval from Health Canada to prevent shingles (herpes zoster) in people aged 50 or older. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 15, 2017 Category: Pharmaceuticals Source Type: news

GSK Shingles Vaccine Shingrix Gets First Okay in Canada GSK Shingles Vaccine Shingrix Gets First Okay in Canada
Shingrix, given in two doses 2 to 6 months apart, is for adults aged 50 years and older. It was shown to achieve ≥ 90% efficacy in clinical trials.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2017 Category: Consumer Health News Tags: Infectious Diseases News Alert Source Type: news

GlaxoSmithKline's shingles vaccine gets approval in Canada
(Reuters) - Canadian health regulators have approved GlaxoSmithKline's key shingles vaccine, the company said on Friday. (Source: Reuters: Health)
Source: Reuters: Health - October 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Most Physicians Say Shingrix Important Development for Shingles Most Physicians Say Shingrix Important Development for Shingles
Although many primary care providers were unfamiliar with the shingles vaccine, they were impressed with it after they learned about it.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 11, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Shingles Quiz: Symptoms, Vaccine & Pictures
Title: Shingles Quiz: Symptoms, Vaccine& PicturesCategory: MedicineNet QuizCreated: 6/11/2010 12:00:00 AMLast Editorial Review: 9/19/2017 5:50:16 PM (Source: MedicineNet Skin General)
Source: MedicineNet Skin General - September 19, 2017 Category: Dermatology Source Type: news

FDA Advisers Recommend Approval of New Shingles Vaccine (FREE)
By the Editors An FDA advisory panel voted 11-0 on Wednesday in favor of approving the Shingrix herpes zoster vaccine for adults … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 14, 2017 Category: Primary Care Source Type: news

US FDA advisory committee votes for GSK ’s Shingrix to prevent shingles
The US Food and Drug Administration ’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) has voted unanimously for GlaxoSmithKline’s (GSK) Shingrix (HZ/su) to prevent herpes zoster (shingles) in adults of 50 years of age and a… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 13, 2017 Category: Pharmaceuticals Source Type: news

FDA Panel Recommends New Shingles Vaccine FDA Panel Recommends New Shingles Vaccine
An FDA panel unanimously recommended zoster vaccine recombinant (adjuvanted) (Shingrix, GlaxoSmithKline) for adults aged 50 years and older.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

GSK's shingles vaccine gets positive FDA recommendation
A Food and Drug Administration advisory panel voted unanimously Wednesday to recommend approval for GlaxoSmithKline's new drug candidate Shingrix, a vaccine for preventing shingles in adults age 50 and older. The vote by the Vaccines and Related Biological Products Advisory Committee was 11-0 in support of the biologics license application submitted by GlaxoSmithKline last October. The committee's recommendation is nonbinding, but the FDA typically follows the advice of its advisory panels. If… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 13, 2017 Category: Biotechnology Authors: John George Source Type: news

GSK's shingles vaccine gets positive FDA recommendation
A Food and Drug Administration advisory panel voted unanimously Wednesday to recommend approval for GlaxoSmithKline's new drug candidate Shingrix, a vaccine for preventing shingles in adults age 50 and older. The vote by the Vaccines and Related Biological Products Advisory Committee was 11-0 in support of the biologics license application submitted by GlaxoSmithKline last October. The committee's recommendation is nonbinding, but the FDA typically follows the advice of its advisory panels. If… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 13, 2017 Category: American Health Authors: John George Source Type: news

'Impressed' FDA panel unanimously recommends GSK shingles vaccine
(Reuters) - A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline's Shingrix shingles vaccine warrants approval for its use in adults aged 50 and over. (Source: Reuters: Health)
Source: Reuters: Health - September 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA panel unanimously votes to recommend GSK shingles vaccine
(Reuters) - A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline's Shingrix shingles vaccine warrants approval for its use in adults aged 50 and over. (Source: Reuters: Health)
Source: Reuters: Health - September 13, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Advisory Committee Votes Unanimously for Shingrix (HZ/su) in the US for Prevention of Herpes Zoster (Shingles) in Adults Ages 50 and Over
London UK 13 September 2017 -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) voted unanimously that the data support the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 13, 2017 Category: Drugs & Pharmacology Source Type: news

Lexington biotech Agenus files patent for herpes vaccine
A Lexington biotech working on a vaccine for shingles is also exploring a vaccine for herpes. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 8, 2017 Category: American Health Authors: Jessica Bartlett Source Type: news

Tofacitinib After Live Shingles Vaccination Does Not Impair Immunogenicity Tofacitinib After Live Shingles Vaccination Does Not Impair Immunogenicity
Tofacitinib begun 2 to 3 weeks after live zoster vaccination does not impair immunogenicity, and vaccination appears to be safe in patients with pre-existing varicella-zoster virus (VZV) immunity, researchers report.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - August 31, 2017 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Arthritis treatment news: THIS vaccine should be given to sufferers before medication
ARTHRITIS patients have a higher risk of developing shingles, but researchers have found that a vaccine could boost their immune system. (Source: Daily Express - Health)
Source: Daily Express - Health - August 30, 2017 Category: Consumer Health News Source Type: news

New Herpes Zoster Vaccine Close to FDA Approval
A new recombinant adjuvanted herpes zoster vaccine awaiting potential approval from the Food and Drug Administration has been shown to have close to 90% efficacy at 4 years among research participants older than 70 and even those older than 80. (Source: Caring for the Ages)
Source: Caring for the Ages - August 30, 2017 Category: Health Management Authors: Christine Kilgore Source Type: news

Shingles Vax Effective in RA Patients onJAK Inhibitor (CME/CE)
(MedPage Today) -- Study directly assessed safety, immunogenicity of live zoster vaccine (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - August 29, 2017 Category: Rheumatology Source Type: news

Shingles Vax Effective in RA Patients on JAK Inhibitor (CME/CE)
(MedPage Today) -- Study directly assessed safety, immunogenicity of live zoster vaccine (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 29, 2017 Category: Primary Care Source Type: news

Doctors urge shingles vaccine to be used in arthritis patients
Researchers at Oregon Health and Science University found that the live varicella-zoster, or shingles, vaccine boosts the immune response in arthritis patients. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 28, 2017 Category: Consumer Health News Source Type: news

Studies reveal how shingles vaccine should be used in arthritis patients
(Wiley) New research indicates that the live varicella-zoster vaccine -- which is given to protect against shingles -- elicits robust immune responses in patients when administered several weeks prior to the start of treatment with the arthritis drug tofacitinib. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2017 Category: International Medicine & Public Health Source Type: news

Health Tip: One of Three Adults Gets Shingles
-- Adults 60 and older should be vaccinated for shingles, a very painful rash that's triggered by the same virus that causes chickenpox, the U.S. Centers for Disease Control and Prevention says. If you had chickenpox when you were younger, the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2017 Category: General Medicine Source Type: news

Infectious diseases warning: The three vaccinations YOU should have by your 70s
INFECTIOUS diseases are responsible for a significant number of hospital admissions and deaths in the elderly. For this reason, there are particular vaccines recommended for people 65 and over - pneumococcal vaccine, flu vaccine and shingles vaccine. (Source: Daily Express - Health)
Source: Daily Express - Health - August 4, 2017 Category: Consumer Health News Source Type: news

Shingles Vaccination: Why Wait?
ACIP recommends the zoster vaccine be given at age 60 years. That could be too late for some. And, what about this 60-year-old? (Source: ConsultantLive)
Source: ConsultantLive - July 14, 2017 Category: Internal Medicine Authors: Terry Brenneman, MD Tags: Vaccines Source Type: news

Analysis Strengthens Herpes Zoster Link With Stroke, MI Analysis Strengthens Herpes Zoster Link With Stroke, MI
More research is needed to elucidate the effect of antiviral-agent use or vaccination on cardiovascular outcomes after herpes zoster infection, the authors said.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Heart attack and stroke risk higher with shingles
Doctors urged to make patients with shingles aware of their risk of cardiovascular disease Related items fromOnMedica Risk of stroke increases immediately after shingles Vaccine for shingles fails to reach patients in most need (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 4, 2017 Category: UK Health Source Type: news

Older Adults Lacking Shingles, Flu Vaccinations - AARP
3 days ago ... AARP previously reported on the many different vaccinations and what they protect against, who needs them, how often you should get them  ... (Source: AARP.org News)
Source: AARP.org News - July 2, 2017 Category: American Health Source Type: news

Vaccination May Be Curbing ER Visits For Shingles
Vaccination can cut shingles risk by more than half. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - June 29, 2017 Category: Consumer Health News Source Type: news

Gaps Remain in Recommended Vaccines for Older Americans Gaps Remain in Recommended Vaccines for Older Americans
New data suggest room for improvement in influenza, pneumococcal, tetanus, and shingles vaccine coverage among adults aged 65 and older.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Vaccination May Be Curbing ED Visits for Shingles Vaccination May Be Curbing ED Visits for Shingles
Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 28, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Vaccination may be curbing ER visits for shingles
(Reuters Health) - Emergency room (ER) visits for shingles fell in the past decade for people aged 60 and older but rose for most younger age groups. The decrease among older people may be due to more of them getting the shingles vaccine, U.S. researchers suggest. (Source: Reuters: Health)
Source: Reuters: Health - June 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Practice nurses called upon to boost London shingles vaccination
Practice nurses and GPs across London are being urged to boost uptake of the shingles vaccine among people aged over 70 years old as part of a city-wide campaign. (Source: Nursing Times)
Source: Nursing Times - June 27, 2017 Category: Nursing Source Type: news

Trends in emergency room visits & costs for patients with shingles
(Brigham and Women's Hospital) Their study suggests that while emergency room visits for shingles has decreased for those vaccinated against either the chicken pox (18 to 19 years old) or the shingles (60 years and older), the patient population in-between (ages 20-59 years old) has experienced increased visits for the disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 21, 2017 Category: Infectious Diseases Source Type: news

I Got Shingles As A Healthy 34-Year-Old, And It Was The Worst Pain I've Ever Felt
By Amanda MacMillan A few weeks after my 34th birthday, my husband and I went for a Saturday hike — a weekly ritual we’d started after moving to New York State’s Catskill Mountains region a few months earlier. I’d been feeling a bit under the weather, and I hoped the fresh autumn air would do me good. It didn’t. Later that night, I had chills and my skin felt strangely sensitive, like when you’re coming down with the flu. On top of that, it felt like I had pulled a muscle in my back or chest; when I breathed or stretched certain ways, I’d get shooting pains across my body. I blamed...
Source: Healthy Living - The Huffington Post - May 4, 2017 Category: Consumer Health News Source Type: news

Thousands damaged by shingles vaccine are trying to sue Merck
(Natural News) What was supposed to be a cure for shingles has brought on worse complications. Thousands have attempted to file lawsuits against American pharmaceutical company Merck & Co. for problems associated with their product Zostavax. In an interview with TROFire.com, Troy Bouk, Associate Attorney at the Levin Papantonio law firm, stated that the side... (Source: NaturalNews.com)
Source: NaturalNews.com - April 27, 2017 Category: Consumer Health News Source Type: news

Vaccines for adults: Which do you need?
It's World Immunization Week, so it's a good time to see if you're up to date on your shots. Just because you're an adult, doesn't mean you shouldn't worry about getting certain vaccinations. Besides influenza you also may need a vaccination for pneumonia, shingles and more.?Find out how to stay on top of the vaccines [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 27, 2017 Category: Databases & Libraries Source Type: news

GSK and Daiichi Sankyo JV submits NDA for candidate shingles vaccine in Japan
GlaxoSmithKline (GSK) and Daiichi Sankyo joint venture (JV) Japan Vaccine Co has submitted a New Drug Application (NDA) in Japan for candidate shingles vaccine, Shingrix. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - April 19, 2017 Category: Pharmaceuticals Source Type: news

Merck in hot water over dangerous shingles vaccine that caused numerous injuries, deaths
(Natural News) Commercials for the jab showing happy people free of shingles are a common feature of television advertising. But Merck & Co’s “Zosatavax” vaccine to prevent varicella, the adult version of chickenpox, is causing the international drug giant some serious headaches after numerous people who got the shot suffered injuries and/or death. Multiple lawsuits... (Source: NaturalNews.com)
Source: NaturalNews.com - April 4, 2017 Category: Consumer Health News Source Type: news

Shingles Vaccine Cuts Chronic Pain, Hospitalizations
Protection lasts years after immunization, researchers foundSource: HealthDay Related MedlinePlus Pages: Immunization, Seniors' Health, Shingles (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 17, 2017 Category: Consumer Health News Source Type: news

Shingles Vaccine Cuts Chronic Pain, Hospitalizations
FRIDAY, March 17, 2017 -- Vaccination greatly reduces the risk of serious complications from shingles, a new study finds. Shingles occurs when the same virus that causes chickenpox is reactivated later in life. Nearly one-third of people in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 17, 2017 Category: Journals (General) Source Type: news

Zostavax
(Source: What's New at CBER)
Source: What's New at CBER - March 16, 2017 Category: Biomedical Science Source Type: news

In First Phase 3 Trial, Merck ’s Investigational Inactivated Varicella Zoster Virus Vaccine (V212) Reduced the Incidence of Confirmed Herpes Zoster Cases by an Estimated 64 Percent in Immunocompromised Subjects
Dateline City: KENILWORTH, N.J.KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first Phase 3 study results for V212, the company ’s investigational inactivated varicella zoster virus vaccine (VZV) for the prevention of herpes zoster or HZ, also known as shingles, in immunocompromised patients.Language: EnglishContact: MerckMedia:Pamela Eisele, 267-305-3558orSkip Irvine, 267-305-0338orInvestors:Amy Klug, 908-740-1898orMichael DeCarbo, 908-740-1807Ticker Slug:Ticker:MRKExchange:NYSE @Merckread more (Source: Merck.c...
Source: Merck.com - Research and Development News - February 24, 2017 Category: Pharmaceuticals Tags: Research and Development News Corporate News Latest News #Merck #MRK $MRK MSD NYSE:MRK Source Type: news

Why Skipping Vaccines Is A Public, Not Personal, Health Choice
(Reuters Health) - Too many U.S. adults are not getting vaccinated, putting themselves and others at risk, immunization experts say. According to the latest available data, about 44 percent of adults over age 19 had a flu shot; 20 percent had a TDAP vaccine, which protects against tetanus, diphtheria and pertussis; and 20 percent of 19-to-64-year-olds at risk of pneumonia had that vaccine (compared to 60 percent of those over 65). Just 27 percent of those over age 60 were vaccinated against herpes zoster, which cuts the risk of shingles in half, according to new guidelines from the Advisory Committee on Immunization P...
Source: Science - The Huffington Post - February 8, 2017 Category: Science Source Type: news

Scientists shocked to learn that shingles vaccines can transform vaccinated people into "carriers" who spread infectious disease
(Natural News) Shingles, also known as “zoster” or “herpes zoster,” will affect roughly 1 out of every 3 American adults during their lifetime. Estimates suggest that there are upwards of one million cases of shingles each year in the United States. The disease is caused by dormant varicella zoster virus — the same virus that... (Source: NaturalNews.com)
Source: NaturalNews.com - January 23, 2017 Category: Consumer Health News Source Type: news

America's Home Care Agencies: Leading the Way in Promoting Public Health
When Marie Desil, a home care nurse with my agency, Visiting Nurse Service of New York (VNSNY), recently took on the case of Doris*, an elderly woman with heart failure, she immediately set to work explaining to Doris and her family how to take her medications properly and manage her symptoms--advice that included limiting Doris' sodium and fluid intake and reporting any sudden weight gain. But Marie's nursing care didn't stop there. "After discussing with Doris and her family the importance of an annual flu shot, I got the okay from her doctor to administer the vaccine on my next visit," she says. "And I'll...
Source: Healthy Living - The Huffington Post - December 16, 2016 Category: Consumer Health News Source Type: news

Diabetes Patients Vary in Uptake of Flu and Other Vaccines Diabetes Patients Vary in Uptake of Flu and Other Vaccines
Although poor people are most likely to have diabetes, among those with diabetes, they are least likely to have received vaccines for influenza, pneumococcus, hepatitis B, and shingles, new data indicate.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - December 13, 2016 Category: Allergy & Immunology Tags: Diabetes & Endocrinology News Source Type: news

The New Old Age: Older Adults Are Still Skipping Vaccinations
People once vigilant about immunizing their children aren ’ t nearly as careful about protecting themselves as they age. (Source: NYT Health)
Source: NYT Health - December 2, 2016 Category: Consumer Health News Authors: PAULA SPAN Tags: Shingles (Disease) Vaccination and Immunization Elderly Influenza Health Insurance and Managed Care Source Type: news

Herpes zoster (shingles) immunisation programme 2015 to 2016: evaluation report
This report is an evaluation of the third year of the shingles vaccination programme. It highlights the lower coverage achieved in the routine and catch-up cohort in 2015-16 compared with previous years. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 2, 2016 Category: Consumer Health News Source Type: news

GSK Announces EU Regulatory Submission of Candidate Vaccine for Prevention of Shingles
GlaxoSmithKline plc (LSE/NYSE: GSK) has announced the regulatory submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking approval for its candidate shingles vaccine, ShingrixTM, for the prevention of herpes zoster (shingles) in people aged 50 years or over. (Source: World Pharma News)
Source: World Pharma News - November 28, 2016 Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news